Abstract

Safe and successful teclistamab treatment in very elderly multiple myeloma ( MM ) patients : a case report and experience from a total of three octogenarians .

Full Text

Published Version
Open DOI Link

Topics from this Paper

  • Elderly Multiple Myeloma
  • Elderly Multiple Myeloma Patients
  • Multiple Myeloma
  • Multiple Myeloma Patients
  • Case Report
    • + Show 3 more

Create a personalized feed of these topics

Get Started

Get access to 115M+ research papers

Discover from 40M+ Open access, 2M+ Pre-prints, 9.5M Topics and 32K+ Journals.

Sign Up Now! It's FREE

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Comprehensive Geriatric Assessment in Consecutive Newly-Diagnosed Elderly Multiple Myeloma Patients in China: A Multicentered, Prospective, Non-Interventional Study
  • Blood
  • Nov 13, 2019
Relevant
Not Relevant
Outcomes of Autologous Stem Cell Transplantation (ASCT) in Elderly Multiple Myeloma (MM) Patients Aged ≥ 65 Years: A Multi-Centre Australian Experience
  • Blood
  • Nov 29, 2018
Relevant
Not Relevant
Treatment with lenalidomide and dexamethasone for elderly multiple myeloma
  • Feb 5, 2018
Relevant
Not Relevant
Prognostic factors in elderly multiple myeloma patients aged 65 years or older: Comparison with nonelderly patients with multiple myeloma
  • Geriatrics & Gerontology International
  • Oct 28, 2004
Relevant
Not Relevant
P-162: Compass: a prospective study comparing clinical evaluation with different geriatric screening methods in newly diagnosed elderly multiple myeloma patients
  • Clinical Lymphoma Myeloma and Leukemia
  • Oct 1, 2021
Relevant
Not Relevant
高齢者多発性骨髄腫における骨病変の臨床的検討
  • Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics
  • Jan 1, 2002
Relevant
Not Relevant
The Relevance of Minimal Residual Disease (MRD) Monitoring in Elderly Multiple Myeloma (MM) Patients
  • Blood
  • Dec 3, 2015
Relevant
Not Relevant
Determinants of overall survival (OS) of elderly patients with multiple myeloma: A National Cancer Database (NCDB) analysis of years 2004-2017.
  • Journal of Clinical Oncology
  • Jun 1, 2023
Relevant
Not Relevant
The Outcomes of Elderly Multiple Myeloma Patients Treated in the United States
  • Blood
  • Dec 6, 2014
Relevant
Not Relevant
A Single Autologous Stem Cell Transplant (ASCT) Followed By Two Years of Post-Transplant Therapy in Recently Diagnosed Elderly Multiple Myeloma (MM) Patients. Safety and Response Results from the Prospective Phase II Trial (NCT01849783)
  • Blood
  • Nov 29, 2018
Relevant
Not Relevant
Autologous stem cell transplantation in elderly multiple myeloma patients aged ≥65 years: a two‐centre Australian experience
  • Internal Medicine Journal
  • Feb 1, 2021
Relevant
Not Relevant
Biological and Clinical Significance of CD81 Expression by Clonal Plasma Cells in High-Risk Smoldering and Symptomatic Multiple Myeloma (MM) Patients,
  • Blood
  • Nov 18, 2011
Relevant
Not Relevant
Autologous stem cell transplantation in elderly multiple myeloma patients aged ≥65 years: a two‐centre Australian experience
  • Internal Medicine Journal
  • Feb 1, 2021
Relevant
Not Relevant
Impact of Combining Frailty Assessment Systems to Select Elderly Myeloma Patients Eligible for Autologous Peripheral Blood Stem Cell Transplantation
  • Blood
  • Nov 13, 2019
Relevant
Not Relevant
Treatment patterns and outcomes in elderly patients with multiple myeloma
  • Leukemia
  • Sep 5, 2012
Relevant
Not Relevant
READ MORE FROM

Annals of hematology

The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib.
Open Access
Just Published
  • Annals of hematology
  • Nov 28, 2023
Relevant
Not Relevant
Warm autoimmune hemolytic anemia associated with SARS-CoV-2 infection responsive to eculizumab.
Just Published
  • Annals of hematology
  • Nov 27, 2023
Relevant
Not Relevant
Evaluation of the cachexia index using a bioelectrical impedance analysis in elderly patients with non-Hodgkin's lymphoma: A single-center prospective study.
Just Published
  • Annals of hematology
  • Nov 27, 2023
Relevant
Not Relevant
Role and application of chemokine CXCL13 in central nervous system lymphoma.
Just Published
  • Annals of hematology
  • Nov 27, 2023
Relevant
Not Relevant
Madrid Newborn Sickle Cell Disease Cohort: clinical outcomes, stroke prevention and survival.
  • Annals of hematology
  • Nov 18, 2023
Relevant
Not Relevant
Perspectives and challenges of small molecule inhibitor therapy for FLT3-mutated acute myeloid leukemia.
  • Annals of hematology
  • Nov 17, 2023
Relevant
Not Relevant
Screening results and mutation frequency analysis of G6PD deficiency in 1,291,274 newborns in Huizhou, China: a twenty-year experience.
  • Annals of hematology
  • Nov 16, 2023
Relevant
Not Relevant
Factors associated with inpatient mortality during daunorubicin and cytarabine induction in adults with acute myeloid leukemia-a national inpatient sample analysis.
  • Annals of hematology
  • Oct 27, 2023
Relevant
Not Relevant
Unicentric Castleman's disease presenting as amyloid A cardiac amyloidosis: a case report.
  • Annals of hematology
  • Oct 26, 2023
Relevant
Not Relevant
Correction to: Prognostic relevance of sarcopenia, geriatric, and nutritional assessments in older patients with diffuse large B‐cell lymphoma: results of a multicentric prospective cohort study.
  • Annals of hematology
  • Oct 26, 2023
Relevant
Not Relevant